Similarly, PRSS1, another PRSS3 protein family member, was reported to be negatively associated with the sensitivity of ovarian cancer cells to cetuximab, which functions by cleaving cetuximab thus leading to resistance [30]. Here, PRSS3 is linked to ovarian cancer.